India to Pakistan: Sofosbuvir Export Trade Route
India has recorded 6 verified shipments of Sofosbuvir exported to Pakistan, representing a combined trade value of $2.4M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $400.5K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED , which accounts for 55% of total export value with 3 shipments worth $1.3M USD. On the buying side, AGP LIMITED, is the largest importer in Pakistan with $1.1M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Pakistan Sofosbuvir corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $2.4M USD. The route is dominated by MYLAN LABORATORIES LIMITED , which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's sofosbuvir manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $400.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (40%) and air (60%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 5.5%, placing it at rank #3 among India's top sofosbuvir export destinations globally.
On the import side, key buyers of Indian sofosbuvir in Pakistan include AGP LIMITED, , AGP LIMITED, NATIONAL TB CONTROL PROGRAM (NTP) and 2 others. AGP LIMITED, is the single largest importer with 1 shipments valued at $1.1M USD.
